×
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   291.46 (+0.92%)
AAPL   144.15 (+0.86%)
MSFT   266.64 (+0.16%)
META   171.07 (+0.77%)
GOOGL   2,324.32 (+1.43%)
AMZN   114.84 (+0.45%)
TSLA   707.87 (+1.82%)
NVDA   154.94 (+2.41%)
NIO   22.60 (+8.50%)
BABA   123.30 (+3.51%)
AMD   77.31 (+2.60%)
MU   59.04 (+2.91%)
T   21.16 (+0.33%)
GE   62.42 (+1.38%)
F   11.46 (+3.62%)
DIS   96.58 (+0.52%)
AMC   12.84 (+2.15%)
PFE   53.36 (+1.16%)
PYPL   73.88 (+0.87%)
NFLX   187.71 (+1.98%)
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   291.46 (+0.92%)
AAPL   144.15 (+0.86%)
MSFT   266.64 (+0.16%)
META   171.07 (+0.77%)
GOOGL   2,324.32 (+1.43%)
AMZN   114.84 (+0.45%)
TSLA   707.87 (+1.82%)
NVDA   154.94 (+2.41%)
NIO   22.60 (+8.50%)
BABA   123.30 (+3.51%)
AMD   77.31 (+2.60%)
MU   59.04 (+2.91%)
T   21.16 (+0.33%)
GE   62.42 (+1.38%)
F   11.46 (+3.62%)
DIS   96.58 (+0.52%)
AMC   12.84 (+2.15%)
PFE   53.36 (+1.16%)
PYPL   73.88 (+0.87%)
NFLX   187.71 (+1.98%)
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   291.46 (+0.92%)
AAPL   144.15 (+0.86%)
MSFT   266.64 (+0.16%)
META   171.07 (+0.77%)
GOOGL   2,324.32 (+1.43%)
AMZN   114.84 (+0.45%)
TSLA   707.87 (+1.82%)
NVDA   154.94 (+2.41%)
NIO   22.60 (+8.50%)
BABA   123.30 (+3.51%)
AMD   77.31 (+2.60%)
MU   59.04 (+2.91%)
T   21.16 (+0.33%)
GE   62.42 (+1.38%)
F   11.46 (+3.62%)
DIS   96.58 (+0.52%)
AMC   12.84 (+2.15%)
PFE   53.36 (+1.16%)
PYPL   73.88 (+0.87%)
NFLX   187.71 (+1.98%)
S&P 500   3,885.92 (+1.06%)
DOW   31,296.66 (+0.83%)
QQQ   291.46 (+0.92%)
AAPL   144.15 (+0.86%)
MSFT   266.64 (+0.16%)
META   171.07 (+0.77%)
GOOGL   2,324.32 (+1.43%)
AMZN   114.84 (+0.45%)
TSLA   707.87 (+1.82%)
NVDA   154.94 (+2.41%)
NIO   22.60 (+8.50%)
BABA   123.30 (+3.51%)
AMD   77.31 (+2.60%)
MU   59.04 (+2.91%)
T   21.16 (+0.33%)
GE   62.42 (+1.38%)
F   11.46 (+3.62%)
DIS   96.58 (+0.52%)
AMC   12.84 (+2.15%)
PFE   53.36 (+1.16%)
PYPL   73.88 (+0.87%)
NFLX   187.71 (+1.98%)
ETR:FME

Fresenius Medical Care AG & Co. KGaA Stock Forecast, Price & News

€47.47
+0.21 (+0.44%)
(As of 07/6/2022 12:00 AM ET)
Add
Compare
Today's Range
€47.33
€48.44
50-Day Range
€45.02
€60.40
52-Week Range
€43.53
€71.14
Volume
509,921 shs
Average Volume
704,197 shs
Market Capitalization
$13.91 billion
P/E Ratio
15.93
Dividend Yield
2.83%
Price Target
€65.55

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
38.1% Upside
€65.55 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.95
Upright™ Environmental Score
News Sentiment
1.05mentions of Fresenius Medical Care AG & Co. KGaA in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.05 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive FME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

Fresenius Medical Care AG & Co. KGaA logo

About Fresenius Medical Care AG & Co. KGaA (ETR:FME) Stock

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FME Stock News Headlines

Fresenius Medical Care goes ex-dividend tomorrow
Is Fresenius Medical Care (FMS) A Smart Investment Choice?
See More Headlines

Industry, Sector and Symbol

Industry
Medical Care
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
122,909
Year Founded
N/A

Company Calendar

Today
7/07/2022
Next Earnings (Estimated)
8/02/2022

Price Target and Rating

Average Stock Price Forecast
€65.55
High Stock Price Forecast
€82.20
Low Stock Price Forecast
€51.00
Forecasted Upside/Downside
+38.1%
Consensus Rating
N/A
Rating Score (0-4)
0
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$17.96 billion
Cash Flow
€3.99 per share
Book Value
€45.17 per share

Miscellaneous

Free Float
N/A
Market Cap
$13.91 billion
Optionable
Not Optionable
Beta
N/A














Fresenius Medical Care AG & Co. KGaA Frequently Asked Questions

What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2022?

0 analysts have issued 1-year price targets for Fresenius Medical Care AG & Co. KGaA's stock. Their FME stock forecasts range from €51.00 to €82.20. On average, they anticipate Fresenius Medical Care AG & Co. KGaA's stock price to reach €65.55 in the next twelve months. This suggests a possible upside of 38.1% from the stock's current price.
View analysts' price targets for Fresenius Medical Care AG & Co. KGaA
or view top-rated stocks among Wall Street analysts.

How has Fresenius Medical Care AG & Co. KGaA's stock performed in 2022?

Fresenius Medical Care AG & Co. KGaA's stock was trading at €57.14 at the beginning of 2022. Since then, FME shares have decreased by 16.9% and is now trading at €47.47.
View the best growth stocks for 2022 here
.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

Fresenius Medical Care AG & Co. KGaA is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022.
View our earnings forecast for Fresenius Medical Care AG & Co. KGaA
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA(ETR:FME) pays an annual dividend of €1.35 per share and currently has a dividend yield of 2.83%. The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 45.30%. This payout ratio is at a healthy, sustainable level, below 75%.

Who are Fresenius Medical Care AG & Co. KGaA's key executives?

Fresenius Medical Care AG & Co. KGaA's management team includes the following people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Management Board & CEO of Fresenius Medical Care Management AG (Age 67, Pay $3.44M)
  • Ms. Helen Giza, Chief Transformation Officer, CFO & Member of Mgmt Board of Fresenius Medical Care Mgmt AG (Age 54, Pay $1.78M)
  • Dr. Franklin W. Maddux F.A.C.P., Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG (Age 65, Pay $1.59M)
  • Mr. William Valle, Management Board Member for Care Delivery of Fresenius Medical Care Management AG (Age 62, Pay $3.93M)
  • Dr. Katarzyna Mazur-Hofsab Ph.D., Management Board Member for Care Enablement of Fresenius Medical Care Management AG (Age 59, Pay $4.37M)
  • Mr. Roberto Fuste, Exec. Advisor for Regional Strategy (Age 70)
  • Dr. Nwamaka Eneanya M.D., Head of Strategy & Operations
  • Dr. Dominik Heger, Exec. VP and Head of Investor Relations, Strategic Devel. & Communications
  • Mr. Borries Von Muller, Sr. VP of Global HR Employee Communications (Age 61)
  • Mr. Joachim Weith, Sr. VP of Corp. Communications & Gov.al Affairs

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Petra Diamonds (PDL), (NOKIA), Fresenius Medical Care AG & Co. KGaA (FMS), RWE Aktiengesellschaft (RWE), Deutsche Lufthansa (LHA), Rio Tinto Group (RIO), Covestro (1COV), Carillion (CLLN), Nokia Oyj (NOK) and Oxford Biomedica (OXB).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the ETR under the ticker symbol "FME."

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FME stock can currently be purchased for approximately €47.47.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has a market capitalization of $13.91 billion and generates $17.96 billion in revenue each year.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

Fresenius Medical Care AG & Co. KGaA employs 122,909 workers across the globe.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The official website for Fresenius Medical Care AG & Co. KGaA is www.freseniusmedicalcare.com. The company can be reached via phone at +49-6172-6090.

This page (ETR:FME) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.